默克集团拟借助瓦罗健康的药物研发人工智能技术

环球市场播报11-20

德国默克集团（Merck KGaA）于周四宣布，已同意采用总部位于美国波士顿的瓦罗健康公司（Valo Health）的药物研究服务，双方将围绕帕金森病及相关疾病开展合作。对这家美国公司（瓦罗健康）而言，该合作的潜在价值可能超过 30 亿美元。　　此次合作聚焦于发掘具有潜力的治疗性分子，凸显出默克集团在以 39 亿美元收购罕见癌症治疗专业企业斯普林沃克斯（SpringWorks）后，希望推动其制药...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2584280136?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-20 20:03","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2584280136","market":"hk","top_or_hot":-1,"title":"默克集团拟借助瓦罗健康的药物研发人工智能技术","media":"环球市场播报","content":"<div>\n<p>德国默克集团（Merck KGaA）于周四宣布，已同意采用总部位于美国波士顿的瓦罗健康公司（Valo Health）的药物研究服务，双方将围绕帕金森病及相关疾病开展合作。对这家美国公司（瓦罗健康）而言，该合作的潜在价值可能超过 30 亿美元。\n　　此次合作聚焦于发掘具有潜力的治疗性分子，凸显出默克集团在以 39 亿美元收购罕见癌症治疗专业企业斯普林沃克斯（SpringWorks）后，希望推动其制药...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-11-20/doc-infyafyw0709218.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>默克集团拟借助瓦罗健康的药物研发人工智能技术</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n默克集团拟借助瓦罗健康的药物研发人工智能技术\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-20 20:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2025-11-20/doc-infyafyw0709218.shtml><strong>环球市场播报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>德国默克集团（Merck KGaA）于周四宣布，已同意采用总部位于美国波士顿的瓦罗健康公司（Valo Health）的药物研究服务，双方将围绕帕金森病及相关疾病开展合作。对这家美国公司（瓦罗健康）而言，该合作的潜在价值可能超过 30 亿美元。\n　　此次合作聚焦于发掘具有潜力的治疗性分子，凸显出默克集团在以 39 亿美元收购罕见癌症治疗专业企业斯普林沃克斯（SpringWorks）后，希望推动其制药...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-11-20/doc-infyafyw0709218.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2361045086.USD","symbol_name":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-20/doc-infyafyw0709218.shtml","article_id":"2584280136","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584280136","pubTimestamp":1763640180,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"德国默克集团于周四宣布，已同意采用总部位于美国波士顿的瓦罗健康公司的药物研究服务，双方将围绕帕金森病及相关疾病开展合作。对这家美国公司而言，该合作的潜在价值可能超过 30 亿美元。　　瓦罗健康在一份声明中表示，此次合作的预付款及基于研发成果的里程碑付款总额可能超过 30 亿美元，此外还将包括专利使用费和研发资金支持。　　默克集团在声明中指出，该合作将助力公司在最具潜力的候选药物研发上取得更快进展。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161631":"人工智能","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","LU0861579265.USD":"联博低波幅策略股票基金A","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0234572021.USD":"高盛美国核心股票组合Acc","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","BK4007":"制药","LU0058720904.USD":"联博国际健康护理基金A","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","SG9999001176.USD":"United Global Healthcare Acc USD","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU1037948897.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (HKD) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","MRK":"默沙东","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","BK4534":"瑞士信贷持仓","LU1037948541.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (HKD) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","SG9999014575.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USDHDG) INC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4516":"特朗普概念","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC"},"translate_title":"Merck plans to use Varo Health's drugs to develop artificial intelligence technology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161631":1.5,"MRK":1.5},"content_text":"德国默克集团（Merck KGaA）于周四宣布，已同意采用总部位于美国波士顿的瓦罗健康公司（Valo Health）的药物研究服务，双方将围绕帕金森病及相关疾病开展合作。对这家美国公司（瓦罗健康）而言，该合作的潜在价值可能超过 30 亿美元。\n　　此次合作聚焦于发掘具有潜力的治疗性分子，凸显出默克集团在以 39 亿美元收购罕见癌症治疗专业企业斯普林沃克斯（SpringWorks）后，希望推动其制药部门恢复增长的雄心。\n　　瓦罗健康在一份声明中表示，此次合作的预付款及基于研发成果的里程碑付款总额可能超过 30 亿美元，此外还将包括专利使用费和研发资金支持。\n　　由家族控股的默克集团，此前在后期药物试验中遭遇了一系列备受关注的挫折（例如去年决定终止头颈癌药物 Xevinapant 的研发），因此目前迫切希望加强其药物研发管线。\n　　默克集团在声明中指出，该合作将助力公司在最具潜力的候选药物研发上取得更快进展。\n　　这家业务多元化的集团还涉足其他领域：一是半导体生产用化学品业务（该业务受益于人工智能领域的投资）；二是生物技术药物生产所需的实验室耗材业务。\n　　瓦罗健康成立于 2019 年，是一家生物技术公司，主要通过数据分析和人工智能技术为药物发现与研发提供支持。\n　　瓦罗健康表示，其医疗研究服务的基础是超过 1700 万份患者病历和生物样本，同时会严格保护数据隐私。\n　　据估算，仅美国就有约 100 万人患有帕金森病，而目前已有的治疗方法仅能缓解症状。多年来，制药行业一直在努力研发更有效的治疗药物，但期间遭遇了多次挫折。\n　　对默克集团而言，此次合作标志着其重返帕金森病治疗领域。此前，该公司曾在 2006 年一项关键的后期试验中失败，并于 2011 年终止了与纽龙制药（Newron）在另一种帕金森病候选药物上的合作。\n　　瓦罗健康在该领域也十分活跃：今年 9 月，该公司获得了迈克尔・J・福克斯基金会（The Michael J． Fox Foundation，致力于帕金森病研究的知名机构）的研究资助，用于探索治疗帕金森病的新方法。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584280136","isCrawlerRequest":true}